| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |